U.S. consumer confidence slumped to the lowest level in more than 11-1/2 years in January amid mounting anxiety over a sluggish labor market and high prices, which could see households becoming more cautious about spending. ...

Mexican President Claudia Sheinbaum, pressed on Tuesday whether Mexico had halted oil shipments to Cuba amid pressure from Washington, said shipment decisions were sovereign in nature and not based on... ...

Amazon said on Tuesday it would expand its same-day delivery service to more U.S. cities this year while closing some of its Amazon Go and Amazon Fresh physical locations to convert them into Whole Fo... ...

Core Insights - Cloudflare shares experienced a significant increase of approximately 14% in premarket trading, driven by renewed investor interest in the company's AI tools, particularly the "Clawdbot" AI agent [1] Company Summary - The surge in Cloudflare's stock price indicates a positive market reaction to developments surrounding its AI capabilities [1] - The "Clawdbot" AI agent has become a focal point for social media discussions, suggesting a growing enthusiasm for Cloudflare's technological offerings [1]

A fatal collision between an American Airlines regional jet and an Army Black Hawk helicopter near Reagan Washington National Airport in January 2025 was the result of a "multitude of errors" and "sys... ...

Food distributor Sysco lifted its annual profit forecast and beat estimates for both second-quarter profit and sales on Tuesday, as strong demand for its steaks, fillets and frozen-food products helpe... ...

Boeing and Israel's Technion university said on Tuesday they were beginning to develop Sustainable Aviation Fuel (SAF) from feedstocks including green hydrogen and carbon dioxide to enable the aviatio... ...

India's crude oil imports rose 1.6% month-on-month in December to 21.59 million metric tons, their highest level since March, government data showed on Tuesday. ...

Core Viewpoint - Intellia Therapeutics has received approval from the U.S. Food and Drug Administration to lift a clinical hold on one of its late-stage gene therapy trials, enabling the company to resume testing its experimental treatment [1] Group 1 - The FDA's decision allows Intellia to continue its clinical trial, which is crucial for the development of its gene therapy [1] - The lifting of the clinical hold is a significant milestone for Intellia, potentially impacting its future growth and market position [1]

With its first activist campaign in three years, hedge fund Third Point will try to force CoStar Group , the owner of Apartments.com and Homes.com, to change board directors and restructure operation... ...